Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

The revenue from operations jumped 43% YoY to ₹291 crore in Q2 FY25, compared to ₹203 crore in the same quarter of the previous year.

The Glass-Lined Equipment (GLE) industry is poised for significant growth, driven by multiple factors. GLE protects the ...

We have pieced together accounts from multiple reliable sources to build a picture of everyday life for Nasim and other women, who are currently being held in Evin prison. Many were among the tens ...

HBM Healthcare Investments AG / Key word (s): Quarter Results HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year 03-Jan-2025 / 17:48 CET/CEST Release ...

Anthem Biosciences Limited, an innovation-driven and technology-focused contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug ...